Insider Transactions Reported by 19 Insiders of Elutia Inc.

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Silver Spring, MD

Insiders trading volume in the past year

Elutia Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
HighCape Capital, L.P. Director, 10%+ Owner $23.8M +$2.1M +9.68% Feb 3, 2025
HighCape Capital, LLC 10%+ Owner $13M Jul 30, 2024
Birchview Capital, LP 10% Owner in previous filing $3.99M Dec 31, 2023
Kevin Rakin Director, 10%+ Owner $3.73M Dec 11, 2025
Elutia PIPE Investment, LP 10%+ Owner $3.46M Sep 21, 2023
C. Randal Mills PRESIDENT AND CEO, Director $1.32M +$13.1K +1% Dec 10, 2025
Michelle LeRoux Williams Chief Scientific Officer $447K Dec 10, 2025
Matthew Ferguson Chief Financial Officer $271K +$6.61K +2.5% Dec 10, 2025
Ronald K. Lloyd PRESIDENT AND CEO, Director $173K Mar 8, 2022
Guido Neels Director $50.9K Dec 1, 2025
Darryl Roberts Evp, Operations & Product Dev. $49.1K Mar 8, 2022
Thomas Englese Chief Commercial Officer $47.7K Mar 8, 2023
Jerome Riebman Chief Medical Officer $36.1K Sep 8, 2022
David Colpman Director $13.8K +$11.5K +500% Nov 17, 2025
Peter G. Edwards General Counsel $8.43K Sep 8, 2022
HighCape Partners GP II, LLC 10%+ Owner Dec 22, 2022
Matt Zuga Director, 10%+ Owner May 29, 2025
Maybelle Jordan Director May 29, 2025
Brigid Makes Director May 29, 2025

Recent Insider Transactions by Companies or Individuals for Elutia Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.